Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.25479 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.18233 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16036 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15755 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.09696 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.31266 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.1896 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.17197 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1725 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.16017 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17119 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16705 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.18094 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.17735 | 49 |